A significant institutional options trade on Abbott Laboratories (ABT) signals strong confidence in the healthcare giant's legal resilience and valuation floor, presenting a unique risk/reward opportunity for investors.
Despite a recent stock dip, Brookfield Asset Management (BAM) is drawing investor attention for its aggressive growth strategy and operational moat. We analyze the bull case, weighing its fee-earnings trajectory against a premium valuation and macroeconomic headwinds.
Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to provide depositions to the House Oversight Committee, in a last-minute move to avert a congressional contempt vote scheduled for this week.
Amidst a strategic merger with New Gold and a multi-year production expansion plan, Coeur Mining emerges as a compelling North American precious metals play. Analysts point to a significant gap between its current market valuation and underlying fundamentals.
The abrupt Chapter 7 filing of Synergy World Inc., a key gift card partner for Costco, has exposed vulnerabilities in the popular discount gift card market, leaving thousands of cardholders with potentially worthless credits and highlighting broader consumer protection gaps.
Shares of Malaysian bottled water leader Spritzer Bhd have jumped nearly 10% in a month, outpacing the broader market. Analysts point to the company's robust return on equity and consistent profit reinvestment as key drivers behind investor confidence and its impressive earnings growth trajectory.
Marius Borg Høiby, the 29-year-old son of Norway's Crown Princess Mette-Marit, stands trial in Oslo on 38 charges including the alleged rape of four women and assaults on former partners, in a case that has shaken the monarchy's public image.
Demonstrators in Italy have used humor and local cultural touchstones to craft pointed protests against US Immigration and Customs Enforcement (ICE) policies, blending food rules with political dissent.
State Rep. James Talarico pushes back against claims he called former Congressman Colin Allred a 'mediocre Black man,' attributing the dispute to a misinterpreted private conversation as a heated Democratic primary intensifies.
Amid market volatility, H&R Block (HRB) presents a compelling value proposition. With aggressive share buybacks, robust cash flow, and strategic expansion beyond tax season, the financial services firm is drawing investor attention for its resilience and shareholder returns.
As soaring home prices and mortgage rates lock out buyers, the single-family rental market is booming. Investment analysts are making a bullish case for industry leader Invitation Homes (INVH), citing its massive scale, near-full occupancy, and a dividend yield that looks attractive against a backdrop of resilient housing demand.
Following a sharp post-spinoff rally and subsequent pullback, Starz Entertainment (STRZ) is drawing value investors with its deep discount, niche content strategy, and a restructuring plan aimed at sustainable cash flow. Activist stakes and potential M&A add further intrigue to the story.
After years of struggle, Oatly Group AB (OTLY) is showing concrete signs of a sustainable turnaround, posting its first quarterly operating profit in ten years. Strategic moves, including debt restructuring and a key investor stake, are fueling optimism for the oatmilk pioneer's path to profitability.
The House is poised to vote Tuesday on a Senate-passed funding package to reopen most federal agencies, while a two-week stopgap for the Department of Homeland Security sets the stage for a fierce immigration policy battle.
A massive release of Jeffrey Epstein investigation files by the Justice Department has left survivors reeling after personal information, including names and confidential statements, was left unredacted. Lawyers allege a "historic violation" of privacy, prompting urgent calls for judicial intervention.
Insurance brokerage giant Brown & Brown is grappling with a significant talent drain to a rival, launching legal action to stem the flow, while also mourning the loss of its top lawyer. These challenges unfold against a backdrop of a sharply declining share price, raising questions about the firm's near-term stability and strategic direction.
Adtalem Global Education posts strong Q2 fiscal 2026 results, raising revenue to $503.39M and net income to $76.38M, while reaffirming full-year guidance. The company's new $750M share repurchase authorization signals a dual commitment to capital returns and strategic growth in its healthcare education portfolio, even as regulatory and enrollment challenges linger.
Crane Company's shares have soared over 700% in three years, but recent volatility has investors questioning if the rally is sustainable. A deep dive into valuation metrics reveals a complex picture where traditional models clash.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
The data analytics firm's quarterly results soared past estimates, fueled by surging government contracts. CEO Alex Karp touts 'iconic' performance while facing renewed scrutiny over the company's role in immigration enforcement.
